Submitted by mike kraft on
At least 766,383 people globally have died from COVID-19 and 21,577,190 have been infected by the novel coronavirus that causes it, following an outbreak that started in Wuhan, China, in early December. The World Health Organization referred to it as a pandemic on March 11, 2020.
Submitted by mike kraft on
CNN)With so much information available about the severity of the coronavirus and the need to follow guidelines, some people still refuse to accept reality.
Submitted by mike kraft on
Submitted by mike kraft on
For months, public health experts and federal officials have said that significantly expanding the number of coronavirus tests administered in the United States is essential to reining in the pandemic. By some estimates, several million people might need to be tested each day, including many people who don’t feel sick.
But the country remains far short of that benchmark and, for the first time, the number of known tests conducted each day has fallen.
Submitted by mike kraft on
Two senior Trump political appointees departed the US Centers for Disease Control and Prevention, a senior official at the agency confirmed to CNN.
Submitted by mike kraft on
Submitted by mike kraft on
SEOUL, South Korea (AP) — South Korea on Saturday announced stronger social distancing restrictions for its greater capital area where a surge in COVID-19 cases has threatened to erase the hard-won gains against the virus.
Submitted by mike kraft on
PARIS (AP) — New flareups of COVID-19 are disrupting the peak summer vacation season across much of Europe, where authorities in some countries are reimposing restrictions on travelers, closing nightclubs again, banning fireworks displays and expanding mask orders even in chic resort areas.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
As the coronavirus pandemic continues to wreak havoc in the United States and treatments are needed more than ever, clinical trials for some of the most promising experimental drugs are taking longer than expected.
Researchers at a dozen clinical trial sites said that testing delays, staffing shortages, space constraints and reluctant patients were complicating their efforts to test monoclonal antibodies, man-made drugs that mimic the molecular soldiers made by the human immune system.
Submitted by mike kraft on
Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they’ll ever get a clear answer.
